siRNA, Anti-ATP5MD, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT51075WQ-2OMe)

The product SIRGT51075WQ-2OMe is a type of small interfering RNA (siRNA) that targets ATP5MD gene and regulates the expression of gene. The siRNA interferes with the expression of ATP5MD gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001206426.1
Alternative Names DAPIT; HCVFTP2; USMG5; bA792D24.4
Related Diseases Mitochondrial Complex V Deficiency
Purification HPLC
Target Gene
Gene ID 84833
Uniprot ID Q96IX5
Sub Cat Target Species Modification Scale  
SIRGT52075WQ-2F ATP5MD Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT53075WQ-2MOE ATP5MD Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT54075WQ-LNA ATP5MD Human Locked Nucleic Acid (LNA) Inquiry
SIRGT51075WQ-RB ATP5MD Human Ribo-modified Inquiry
SIRGT52075WQ-BB ATP5MD Human Backbone-modified Inquiry

Related Products